Methylprednisolone After Split-course Chemoradiotherapy For Bulky Local Advanced None-small Cell Lung Cancer

NCT03661567 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

52

Enrollment

OTHER

Sponsor class

Stopped slow enrollment

Conditions

Non-small Cell Lung Cancer

Interventions

RADIATION: chest radiation
DRUG: concurrent chemotherapy
DRUG: Methylprednisolone

Sponsor

Sun Yat-sen University